Evidence map›Paper›PMID 41322004›Full record

ArticleComputational and structural biotechnology journal2025

A universal pipeline MosaicProt enables large-scale modeling and detection of chimeric protein sequences for studies on programmed ribosomal frameshifting.

Umut Çakır, Noujoud Gabed, Ali Yurtseven, Igor Kryvoruchko

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Umut ÇakırClinical Neuroscience Research Group, Max Planck Institute for Multidisciplinary Sciences, The University of Göttingen, Göttingen 37075, Germany.
Noujoud GabedCellular and Molecular Biology Department, Oran High School of Biological Sciences (ESSBO), Oran 31000, Algeria.
Ali YurtsevenFaculty of Electrical and Electronics Engineering, Istanbul Technical University, Istanbul 34485, Turkey.
Igor KryvoruchkoDepartment of Biology, United Arab Emirates University, P.O. Box 15551, Al Ain, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides and proteins produced by programmed ribosomal frameshifting (PRF) are well-known in viruses. In non-viral systems, only a few examples of such chimeric sequences have been documented until recently. Three studies in eukaryotes showed that chimeric peptides are numerous and diverse. In ciliates, such peptides are associated with stop codons. In humans, their discovery was possible due to focusing on sequences with naturally repeated codons. This way, many candidate sequences with mass spectrometry (MS) proteomics-based support for translation have been identified. In a plant study, our group discovered MS-validated chimeric peptides using a unique modeling algorithm, MosaicProt, which is described and made available here. Our pipeline enables the identification of chimeric peptides in any organism for which transcript sequences and MS proteomic data are available. By design, our approach does not require prior knowledge about sequence similarity to already characterized PRF sites and can detect forward and backward frameshifts by 1 and 2 nucleotides. Thus, our pipeline opens a path for uncovering previously unknown PRF events across various transcript types, potentially broadening our understanding of proteome diversity. The pipeline was designed primarily for studies on mosaic translation, hence the name MosaicProt. However, it is applicable for research on PRF in many different contexts.

Indexed as

Alternative open reading frameChimeric peptideMass spectrometry proteomicsMosaic translationProgrammed ribosomal frameshiftingProteome

Identifiers

PMID41322004
PMCPMC12664050

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.